摘要
通过构建绿色荧光蛋白(GFP)和胶质细胞源性神经营养因子(GDNF)共表达的腺病毒载体,讨论其在治疗脊髓和脑有关神经系统疾病的潜在应用价值,了解腺病毒载体在大鼠体内的分布及在体外分泌外源基因产物能力,并对其生物安全性作了初步考察,为GDNF重组腺病毒载体在临床和基础研究中的应用作了一定准备.
A recombinant adenoviral vector harbouring and coexpressing green fluorescent protein (GFP) and glial cell linederived neurotrophic factor (GDNF) was constructed. The construct AdGDNFEGFP was microinjected into the cortex cerebri,corpus striatum,lumbus segment of medulla spinalis,cisternae subarachnoideales and substantia grisea of medulla spinalis of rats. Then the distribution and expression of the exogenous genes in different types of neural cells were observed under fluorescent microscope by using GFP as an indicator. The recombinant virus was used to transfect rat/mouse cell lines NSC and NIH3T3 cells in vitro. The bioengineered cell line coexpressing GDNF and GFP was preliminarily abtained. According to the experimented results,the biosafety and the prospective of applying the adenovector thus constructed to clinical treatment of nervous system diseases were discussed.
出处
《复旦学报(自然科学版)》
CAS
CSCD
北大核心
2003年第4期519-524,531,共7页
Journal of Fudan University:Natural Science
基金
国家"攀登"计划资助项目
关键词
绿色荧光蛋白
胶质细胞源性神经营养因子
重组腺病毒
神经干细胞
神经系统疾病
green fluorescent proteinI(GFP)
glial cell line-derived neurotrophic factor (GDNF)
recombinant adenovirus
neural stem cell
nervous system disease